Medical News
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
New England Journal of Medicine - 29 May 2026 12:00
New England Journal of Medicine, Ahead of Print.
Redefining Early Relapse in Multiple Myeloma - Time to Change the Rules
New England Journal of Medicine - 29 May 2026 12:00
New England Journal of Medicine, Ahead of Print.
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
New England Journal of Medicine - 29 May 2026 12:00
New England Journal of Medicine, Ahead of Print.